Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss

被引:52
|
作者
Aarts, Esther [1 ,2 ]
Helmich, Rick C. [1 ,3 ]
Janssen, Marcel J. R. [1 ,4 ]
Oyen, Wim J. G. [1 ,4 ]
Bloem, Bastiaan R. [1 ,3 ]
Cools, Roshan [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 GC Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Parkinson Ctr Nijmegen ParC, NL-6525 GC Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 GA Nijmegen, Netherlands
关键词
Impulsivity; Dopamine; SPECT; Flexibility; Reward; Parkinson's disease; IMPULSE CONTROL DISORDERS; WORKING-MEMORY; EXTRACELLULAR DOPAMINE; EMISSION-TOMOGRAPHY; COGNITIVE FUNCTION; DECISION-MAKING; MEDICATION; HUMANS; CONNECTIVITY; PERSONALITY;
D O I
10.1016/j.neuroimage.2011.11.073
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine has been implicated in reward-related impulsivity, but the exact relationship between dopamine, reward and impulsivity in humans remains unknown. We address this question in Parkinson's disease (PD), which is characterized by severe dopamine depletion. PD is associated primarily with motor and cognitive inflexibility, but can also be accompanied by reward-related impulsivity. This paradoxical symptom of PD has often been attributed to dopaminergic overstimulation by antiparkinson medication, which is necessary to relieve the motor and cognitive inflexibility. However, factors other than medication may also contribute to aberrant impact of reward. Here we assess whether cognitive inflexibility and aberrant reward impact in PD are two sides of the same coin, namely dopamine cell loss. To measure dopamine cell loss, we employed I-123-FP-CIT Single Photon Emission Computed Tomography (SPECT) in 32 PD patients (10 never-medicated patients and 22 patients after withdrawal of all medication for >12 h) and related the values to behavior on a rewarded task-switching paradigm. Dopamine cell loss was associated not only with cognitive inflexibility (under low reward), but also with aberrant impact of reward. These effects could not be attributed to medication use. Relative to controls (n=26), aberrant reward processing in PD was particularly expressed as reduced capacity to maintain (i.e., repeat) the current task-set under high reward. Our findings demonstrate that factors intrinsically related to PD may underlie the paradoxical symptoms of inflexibility and reward-related impulsivity in PD. The present results concur with observations that low baseline dopamine states predispose to drug and other addictions. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:3339 / 3346
页数:8
相关论文
共 50 条
  • [41] Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression
    Seiler, Jillian L.
    Zhuang, Xiaowen
    Nelson, Alexandra B.
    Lerner, Talia N.
    EXPERIMENTAL NEUROLOGY, 2024, 374
  • [42] Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease
    Greggio, E
    Bergantino, E
    Carter, D
    Ahmad, R
    Costin, GE
    Hearing, VJ
    Clarimon, J
    Singleton, A
    Eerola, J
    Hellström, O
    Tienari, PJ
    Miller, DW
    Beilina, A
    Bubacco, L
    Cookson, MR
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (01) : 246 - 256
  • [43] Pathological Gambling in Patients with Parkinson's Disease is Associated with Fronto-Striatal Disconnection: A Path Modeling Analysis
    Cilia, Roberto
    Cho, Sang Soo
    van Eimeren, Thilo
    Marotta, Giorgio
    Siri, Chiara
    Ko, Ji Hyun
    Pellecchia, Giovanna
    Pezzoli, Gianni
    Antonini, Angelo
    Strafella, Antonio P.
    MOVEMENT DISORDERS, 2011, 26 (02) : 225 - 233
  • [44] Aberrant learning in Parkinson's disease: A neurocomputational study on bradykinesia
    Ursino, Mauro
    Baston, Chiara
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2018, 47 (12) : 1563 - 1582
  • [45] Effects of statins on dopamine loss and prognosis in Parkinson's disease
    Jeong, Seong Ho
    Lee, Hye Sun
    Chung, Seok Jong
    Yoo, Han Soo
    Jung, Jin Ho
    Baik, Kyoungwon
    Lee, Yang Hyun
    Sohn, Young H.
    Lee, Phil Hyu
    BRAIN, 2021, 144 : 3191 - 3200
  • [46] Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat:: Similarities with cell loss in Parkinson's disease
    Rodríguez, M
    Barroso-Chinea, P
    Abdala, P
    Obeso, J
    González-Hernández, T
    EXPERIMENTAL NEUROLOGY, 2001, 169 (01) : 163 - 181
  • [47] Differential Effects of Parkinson's Disease and Dopamine Replacement on Memory Encoding and Retrieval
    MacDonald, Alex A.
    Seergobin, Ken N.
    Owen, Adrian M.
    Tamjeedi, Ruzbeh
    Monchi, Oury
    Ganjavi, Hooman
    MacDonald, Penny A.
    PLOS ONE, 2013, 8 (09):
  • [48] Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease
    Shiner, Tamara
    Seymour, Ben
    Wunderlich, Klaus
    Hill, Ciaran
    Bhatia, Kailash P.
    Dayan, Peter
    Dolan, Raymond J.
    BRAIN, 2012, 135 : 1871 - 1883
  • [49] Microglial responses to dopamine in a cell culture model of Parkinson's disease
    Mastroeni, Diego
    Grover, Andrew
    Leonard, Brian
    Joyce, Jeffrey N.
    Coleman, Paul D.
    Kozik, Brooke
    Bellinger, Denise L.
    Rogers, Joseph
    NEUROBIOLOGY OF AGING, 2009, 30 (11) : 1805 - 1817
  • [50] Intracerebroventricular dopamine for Parkinson's disease
    Devos, David
    Devedjian, Jean-Christophe
    Moreau, Caroline
    ONCOTARGET, 2017, 8 (28) : 45034 - 45035